DiaMedica Therapeutics (DMAC) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.19
-0.18
-0.17
-0.16

Details

Expected EPS
-0.16
Actual EPS
-0.17
Surprise EPS
-0.01
Surprise Percent
+6.25%

Description

DiaMedica Therapeutics (DMAC) has reported earnings of -0.17 per share for Q4 2025.

0 Comments

Share your thoughts